Not Recruiting

Provided below is a list of the clinical trials that are currently in progress to evaluate new mesothelioma treatment protocols. Please note that the enrollment period for the following mesothelioma studies has concluded and no new participants are being recruited at this time.

The purpose of these studies is to determine both the safety and effectiveness of new mesothelioma drugs and treatment therapies. Click on a link to learn more about a study and to get recent update information.

• Tomotherapy Treatment for Mesothelioma

  Conditions:

  Mesothelioma

  Last Updated:

  April 5, 2012

  Status:

  Active, not recruiting

• Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma

  Conditions:

  Malignant Mesothelioma; Metastatic Cancer

  Last Updated:

  March 30, 2012

  Status:

  Active, not recruiting

• Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma

  Conditions:

  Mesothelioma

  Last Updated:

  March 1, 2012

  Status:

  Active, not recruiting

• Dasatinib in Resectable Malignant Pleural Mesothelioma

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  January 26, 2012

  Status:

  Active, not recruiting

• Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma

  Conditions:

  Pleural Malignant Mesothelioma

  Last Updated:

  January 25, 2012

  Status:

  Active, not recruiting

• Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma

  Conditions:

  Mesothelioma

  Last Updated:

  January 20, 2012

  Status:

  Active, not recruiting

• Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  January 12, 2012

  Status:

  Active, not recruiting

• Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer

  Conditions:

  Breast Cancer; Colorectal Cancer; Lung Cancer; Malignant Mesothelioma; Prostate Cancer; Psychosocial Effects of Cancer and Its Treatment; Thymoma and Thymic Carcinoma

  Last Updated:

  January 12, 2012

  Status:

  Active, not recruiting

• An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation

  Conditions:

  Ovarian Neoplasms; Colorectal Neoplasms; Melanoma; Small Cell Lung Cancer; Liposarcoma

  Last Updated:

  January 6, 2012

  Status:

  Active, not recruiting

• Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  December 30, 2011

  Status:

  Active, not recruiting

• Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  December 17, 2011

  Status:

  Active, not recruiting

• An Efficacy Study of MORAb-009 Amatuximab in Subjects With Pleural Mesothelioma

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  December 7, 2011

  Status:

  Active, not recruiting

• Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

  Conditions:

  Advanced Malignant Mesothelioma; Carcinoma of the Appendix; Ovarian Sarcoma; Ovarian Stromal Cancer; Pseudomyxoma Peritonei; Recurrent Colon Cancer; Recurrent Malignant Mesothelioma; Recurrent Ovarian Epithelial Cancer; Recurrent Ovarian Germ Cell Tumor; Stage III Colon Cancer; Stage III Ovarian Epithelial Cancer; Stage III Ovarian Germ Cell Tumor; Stage IV Colon Cancer; Stage IV Ovarian Epithelial Cancer; Stage IV Ovarian Germ Cell Tumor; Unspecified Childhood Solid Tumor, Protocol Specific

  Last Updated:

  November 30, 2011

  Status:

  Active, not recruiting

• Study of CBP501 + Pemetrexed + Cisplatin in Patients With Solid Tumors (Phase I) and Patients With Malignant Pleural Mesothelioma (Phase II)

  Conditions:

  Malignant Pleural Mesothelioma; Solid Tumors

  Last Updated:

  October 31, 2011

  Status:

  Active, not recruiting

• Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  September 27, 2011

  Status:

  Active, not recruiting

• S0509: AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  July 18, 2011

  Status:

  Active, not recruiting

• Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  June 21, 2011

  Status:

  Active, not recruiting

• Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma

  Conditions:

  Solid Tumor; Lymphoma

  Last Updated:

  April 28, 2011

  Status:

  Active, not recruiting

• Sorafenib in Treating Patients With Malignant Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  March 22, 2011

  Status:

  Active, not recruiting

• Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  February 26, 2011

  Status:

  Active, not recruiting

• Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  February 26, 2011

  Status:

  Active, not recruiting

• Pemetrexed Disodium and Gemcitabine in Treating Patients With Malignant Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  February 12, 2011

  Status:

  Active, not recruiting

• Gene Therapy for Pleural Malignancies

  Conditions:

  Pleural Mesothelioma; Metastatic Pleural Effusions

  Last Updated:

  September 29, 2010

  Status:

  Active, not recruiting

• Response Evaluation in Malignant Pleural Mesothelioma

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  September 1, 2010

  Status:

  Active, not recruiting

• Molecular Predictors of Pemetrexed and Carboplatin Response in Tumor Samples of a Series of Malignant Pleural Mesothelioma (MPM) Patients and Genotyping for the TSER Polymorphism

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  September 1, 2010

  Status:

  Active, not recruiting

• Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

  Conditions:

  Cancer

  Last Updated:

  August 7, 2010

  Status:

  Active, not recruiting

• Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

  Conditions:

  Lung Cancer; Malignant Mesothelioma; Metastatic Cancer; Thymoma and Thymic Carcinoma

  Last Updated:

  July 21, 2010

  Status:

  Active, not recruiting

• Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  June 11, 2010

  Status:

  Active, not recruiting

• Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate

  Conditions:

  Pleural Mesothelioma; Malignant Pleural Mesothelioma

  Last Updated:

  December 15, 2009

  Status:

  Active, not recruiting

• Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma

  Conditions:

  Pleural Mesothelioma; Malignant Pleural Mesothelioma

  Last Updated:

  October 30, 2009

  Status:

  Active, not recruiting

• Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma

  Conditions:

  Malignant Mesothelioma; Perioperative/Postoperative Complications

  Last Updated:

  August 19, 2009

  Status:

  Active, not recruiting

• Sorafenib in Previously Treated Malignant Mesothelioma

  Conditions:

  Mesothelioma

  Last Updated:

  August 3, 2009

  Status:

  Active, not recruiting

• Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  July 11, 2009

  Status:

  Active, not recruiting

• ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  April 26, 2009

  Status:

  Active, not recruiting

• Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma

  Conditions:

  Malignant Pleural Mesothelioma

  Last Updated:

  April 21, 2009

  Status:

  Active, not recruiting

• Pazopanib in Treating Patients With Malignant Pleural Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  April 14, 2009

  Status:

  Active, not recruiting

• Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  April 3, 2009

  Status:

  Active, not recruiting

• Rapamycin With Grapefruit Juice for Advanced Malignancies

  Conditions:

  Tumors; Neoplasm Metastasis

  Last Updated:

  February 12, 2009

  Status:

  Active, not recruiting

• Combination Chemotherapy With or Without Surgery and Chemoradiotherapy in Treating Patients With Malignant Pleural Mesothelioma

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  February 6, 2009

  Status:

  Active, not recruiting

• Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  February 6, 2009

  Status:

  Active, not recruiting

• Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  July 23, 2008

  Status:

  Active, not recruiting

• Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura

  Conditions:

  Malignant Mesothelioma

  Last Updated:

  July 23, 2008

  Status:

  Active, not recruiting

• High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma

  Conditions:

  Breast Cancer; Endometrial Cancer; Malignant Mesothelioma

  Last Updated:

  July 23, 2008

  Status:

  Active, not recruiting